Bank of America has provided exclusive financial advisory services for Boston Scientific’s acquisition of Silk Road Medical, valued at $1.26 billion.
Silk Road Medical, known for its innovative devices aimed at reducing stroke risks, is set to enhance Boston Scientific’s cardiology portfolio significantly. Cat Jennings, President of Boston Scientific, emphasized